Chemdiv, Inc.

San Diego, CA

UEI
WZKETC8NCBF1
CAGE
3YJW6
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
12730 High Bluff Dr #100, San Diego, CA 92130, USA
Website
chemdiv.com
Founded
1991
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Industrials
  2. Capital Goods
  3. Construction & Engineering
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 -$54

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Professional And Scientific Associates, Inc. Conduct in vitro screening of interventional agents in high throughput screening (HTS) formats: high throughput screening to identify HIV inhibitors PO… 75N93023F00002 $34,980

Grant awards

Similar vendors

About the company

Chemdiv, Inc., doing business as Chemdiv Inc., is a corporate entity providing integrated drug discovery and early clinical development solutions globally, leveraging advanced technologies to accelerate R&D programs for pharmaceutical and biotech partners. The company has been registered in the System for Award Management (SAM.gov) since 2004 to receive federal contracts and grants.

Chemdiv, Inc. has received several prime federal contract awards from agencies such as the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse, and National Center for Advancing Translational Sciences. These awards were primarily firm-fixed-price purchase orders for the acquisition of compound libraries and chemical compounds to support drug screening and research efforts. For instance, Chemdiv received a $141,500 award from NCATS for an 11,000 compound methyltransferase library, a $103,000 award from NIDA for an 8,000 compound library, and a $21,800 award from NINDS for unspecified compounds. These contracts did not have any set-aside designations. Additionally, Chemdiv has been a sub-contractor to Research Triangle Institute on a federal contract.

SBA capabilities narrative

Diverse and focused/targeted off-shelf and custom drug discovery chemistry, custom discovery solutions, building blocks, hit-to-lead and lead optimization, bioscreening, compound logistics and management, cheminformatics and proprietary equipment.

Over the past 32 years ChemDiv has successfully completed hundreds of leads, candidates and new drug programs to treat cancer, neurological, infectious, cardiometabolic and immune diseases with pharma, biotech and academic partners around the globe. We are revolutionizing the field of drug discovery by harnessing the power of Hybrid Artificial Intelligence (AI) /Machine Learning (ML) which is curated by our scientists at each step in the process.

Quick answers

Is Chemdiv, Inc. registered in SAM.gov?

Yes. Chemdiv, Inc.'s SAM.gov registration is active through December 30, 2026.

What is Chemdiv, Inc.'s CAGE code?

Chemdiv, Inc.'s CAGE code is 3YJW6, and its Unique Entity ID (UEI) is WZKETC8NCBF1.

What is Chemdiv, Inc.'s most recent federal award?

Chemdiv, Inc.'s most recent federal contract award is Chemdiv, INC.:1126869 [21-011017] (75N95A21P00151), from National Institute of Neurological Disorders and Stroke (NIH), on August 17, 2021.

On GovTribe

See Chemdiv, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe